NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE)

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Colorectal Cancer

Countries: France

This multicenter, prospective, observational study will evaluate the efficacy and safety of Avastin (bevacizumab) in first-line therapy in elderly patients with metastatic colorectal cancer. Data will be collected from eligible patients for24 months.

Eligibility overview

Sex: ALL

Age: 75 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Adult patients, \>/= 75 years of age
* Metastatic colorectal cancer
* Initiating Avastin first-line therapy in combination with chemotherapy

Exclusion Criteria:

* Previous Avastin therapy
* Patient participating in a clinical study evaluating a cytotoxic anti-cancer therapy and/or an investigational new drug

Locations (166)

Abbeville, France
Agen, France
Agen, France
Aix-en-Provence, France
Aix-en-Provence, France
Ajaccio, France
Albi, France
Alençon, France
Alençon, France
Amiens, France
Amiens, France
Amiens, France
Amilly, France
Amilly, France
Amilly, France
Angers, France
Arras, France
Arras, France
Aubenas, France
Auch, France
Avignon, France
Bastia, France
Bastia, France
Bayonne, France
Beauvais, France
Besançon, France
Besançon, France
Besançon, France
Béthune, France
Béziers, France
+ 136 more on CT.gov